Good Day BIO Newsletter Archive | October 14, 2020
We recap a fantastic first day of BIO Investor Forum Digital, with a look at VC investment trends, the latest news from the AMR Action Fund, and why diversity matters in clinical trials and in companies. It's all below, plus your usual news from Washington, in just under 1,000 words, just under 5…